Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Late hemotoxicity following North American rattlesnake envenomation treated with crotalidae immune F(ab')<sub>2</sub> (equine) antivenom and crotalidae immune polyvalent Fab (ovine) antivenom reported to the North American Snakebite Sub-registry.

Clinical toxicology (Philadelphia, Pa.)·2022
Same author

Pre-bout hypertension in the combat sports athlete: clearance recommendations.

The Physician and sportsmedicine·2022
Same author

Transesophageal echocardiogram in the evaluation of acute ischemic stroke of young adults.

Brain circulation·2021
Same author

Pediatric Methamphetamine Toxicity: Clinical Manifestations and Therapeutic Use of Antipsychotics-One Institution's Experience.

Journal of medical toxicology : official journal of the American College of Medical Toxicology·2021
Same author

Diagnosis of Hepatopulmonary Syndrome in a Large Integrated Health System.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2020
Same author

Palliative Paracentesis in the Home Setting: A Case Series.

The American journal of hospice & palliative care·2020

Related Experiment Video

Updated: May 8, 2026

Workflow and Framework for Collecting and Implementing Point-of-Care Ultrasound Data in the Management of Heart Failure Patients
03:47

Workflow and Framework for Collecting and Implementing Point-of-Care Ultrasound Data in the Management of Heart Failure Patients

Published on: July 12, 2024

Physician-directed heart failure transitional care program: a retrospective case review.

Ken S Ota1, David S Beutler, Richard D Gerkin

  • 1Banner Good Samaritan Medical Center, Department of Transitional Care Medicine, Phoenix, Arizona, USA.

Journal of Clinical Medicine Research
|August 27, 2013
PubMed
Summary

A hospital-based Heart Failure Transitional Care Program significantly reduced 30-day and 90-day rehospitalization rates for heart failure patients. This physician-directed intervention offers a model for reducing heart failure readmissions.

Keywords:
Heart failureReadmissionTransitional careTransitionalist

More Related Videos

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

Related Experiment Videos

Last Updated: May 8, 2026

Workflow and Framework for Collecting and Implementing Point-of-Care Ultrasound Data in the Management of Heart Failure Patients
03:47

Workflow and Framework for Collecting and Implementing Point-of-Care Ultrasound Data in the Management of Heart Failure Patients

Published on: July 12, 2024

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

Area of Science:

  • Cardiology
  • Healthcare Management
  • Patient Care

Background:

  • National efforts to improve care transitions for heart failure patients at risk of rehospitalization have yielded limited success.
  • Thirty-day rehospitalization rates for heart failure (HF) remain a persistent challenge in healthcare.

Purpose of the Study:

  • To evaluate the effectiveness of a physician-directed Heart Failure Transitional Care Program (HFTCP) in reducing patient rehospitalization.
  • To assess the impact of the HFTCP on 30-day and 90-day readmission rates.

Main Methods:

  • Retrospective review of 73 patients in a hospital-based Heart Failure Transitional Care Program (HFTCP).
  • Analysis of 30- and 90-day readmission rates before and after program enrollment.
  • Intervention included bedside discharge consultation, home visits, frequent phone calls, education, outpatient diuretic therapy, and 24/7 specialist access.

Main Results:

  • Pre-enrollment 30-day readmission rates for acute decompensated heart failure (ADHF) and all-cause were 26.0% and 28.8%, respectively.
  • Post-enrollment 30-day rates significantly decreased to 4.1% (ADHF) and 8.2% (all-cause) (P < 0.001 for both).
  • Pre-enrollment 90-day rates were 58.9% (ADHF) and 69.8% (all-cause), dropping to 16.4% (ADHF) and 27.3% (all-cause) post-enrollment (P < 0.001 for both).

Conclusions:

  • The physician-implemented Heart Failure Transitional Care Program effectively reduced rehospitalization risk in enrolled patients.
  • This program serves as a potential model for other healthcare systems aiming to decrease heart failure readmission rates.